Showing results (2221-2230 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|January 23, 2008
Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipientsG Gerna, D Lilleri, D Caldera, et al.
Bone Marrow Transplantation|January 23, 2008
Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemiaJ Sierra, R Martino, B Sánchez, et al.
Bone Marrow Transplantation|January 31, 2006
Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in childrenM Inoue, T Okamura, M Yasui, et al.
Bone Marrow Transplantation|January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantationS Singhal, L I Gordon, M S Tallman, et al.
Bone Marrow Transplantation|January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Bone Marrow Transplantation|July 24, 2008
Poor prognosis osteosarcoma: new therapeutic approachF Fagioli, E Biasin, O M Mereuta, et al.
Bone Marrow Transplantation|March 7, 2017
A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipientsY Natori, A Humar, J Lipton, et al.
Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.
Bone Marrow Transplantation|May 7, 2014
Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophyM Solders, D A Martin, C Andersson, et al.
Bone Marrow Transplantation|May 8, 2014
Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trialS R Solomon, C A Sizemore, X Zhang, et al.
Pageof 993